Adherence to hormonal therapy in breast cancer patients: EHR-based retrospective data analysis
GMS Medizinische Informatik, Biometrie und Epidemiologie · 17.10.2025 · 21 (Doc18) · Doc18
DOI: 10.3205/mibe000290 ↗Kurz gefasst
Fachartikel in der Zeitschrift GMS Medizinische Informatik, Biometrie und Epidemiologie, erschienen am 17.10.2025. Verfasst von Kim und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Adherence to adjuvant endocrine therapy (AET) is critical for hormone receptor-positive breast cancer but declines over time. We analyzed 6,019 patients from the Asan Biomedical Research Environment (ABLE) who completed five years of anti-estrogen therapy after surgery (2010–2018). Medication adherence, measured by the Medication Possession Ratio (MPR), decreased from 97% to 66%, with especially sharp declines during years 1–2 and 4–5. Poor adherence was associated with age ≥50, aromatase inhibitors (AIs) monotherapy, and absence of radiation therapy (p
Schlagwörter
Zitieren
APA
Kim, Suyeon, Park, Ye-Eun, Lee, Yura, Lee, & Won, J. (2025). Adherence to hormonal therapy in breast cancer patients: EHR-based retrospective data analysis. GMS Medizinische Informatik, Biometrie und Epidemiologie, 21(Doc18), Doc18. https://doi.org/10.3205/mibe000290
Vancouver
Kim, Suyeon, Park, Ye-Eun, Lee, Yura, et al. Adherence to hormonal therapy in breast cancer patients: EHR-based retrospective data analysis. GMS Medizinische Informatik, Biometrie und Epidemiologie. 2025;21(Doc18):Doc18. doi:10.3205/mibe000290
BibTeX
@article{Kim2025,
author = {Kim and Suyeon and Park and Ye-Eun and Lee and Yura and Lee and Won, Jong},
title = {Adherence to hormonal therapy in breast cancer patients: EHR-based retrospective data analysis},
journal = {GMS Medizinische Informatik, Biometrie und Epidemiologie},
year = {2025},
volume = {21},
number = {Doc18},
pages = {Doc18},
doi = {10.3205/mibe000290}
}
EUVIMED